Therapeutic Modulation of Gut Microbiome in Cardiovascular Disease: A Literature Review
Authors:
Open Access
- 24 December 2024
- journal article
- Published by Wolters Kluwer Health in Heart and Mind
- Vol. 9 (1) , 68-79
Abstract
The cardiovascular diseases (CVDs) are a primary global health concern with significant mortality and morbidity. Recent findings suggest that gut microbiota, through its complex interactions with host metabolism, immune response, and inflammation, plays a crucial role in the pathogenesis and progression of CVD. The mechanisms linking gut dysbiosis with cardiovascular risk factors such as hypertension, atherosclerosis, and metabolic syndrome offer a novel perspective on heart health. Excitingly, interventions targeting the microbiome, such as dietary adjustments, probiotics, and prebiotics, hold promise in reducing CVD risks. Adopting personalized approaches to microbiome therapy, tailored to individuals’ unique microbial profiles, could usher in more effective treatments for CVD. As research continues to unveil the intricate role of the gut microbiome, the future of CVD treatment and prevention appears poised for significant transformation. Therefore, this burgeoning field promises to bring about a paradigm shift in cardiovascular health management, with a strong emphasis on personalized, microbiome-based therapeutic strategies, and preventive measures through diet and lifestyle modifications. This review aims to emphasize the potential of integrating the gut microbial insights into clinical practice and how it can be exploited to revolutionize the prevention and management of CVD in future.Keywords
This publication has 80 references indexed in Scilit:
- Role of the gut microbiome in cardiovascular drug response: The potential for clinical applicationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- Human gut microbiota/microbiome in health and diseases: a reviewAntonie van Leeuwenhoek, 2020
- The Effect of Lactobacillus Consumption on Human Blood Pressure: a Systematic Review and Meta-Analysis of Randomized Controlled TrialsComplementary Therapies in Medicine, 2020
- Intestinal Microbiota in Cardiovascular Health and DiseaseJACC, 2019
- Metformin and gut microbiota: their interactions and their impact on diabetesHormones, 2019
- Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirinBiochemical Pharmacology, 2016
- Serious Bleeding Events due to Warfarin and Antibiotic Co-prescription in a Cohort of VeteransThe American Journal of Medicine, 2014
- Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic SteatohepatitisDigestive Diseases and Sciences, 2011
- Systematic Overview of Warfarin and Its Drug and Food InteractionsArchives of internal medicine (1960), 2005